Abstract:Introduction: Despite continued improvement in post-sepsis survival, long term morbidity and mortality remain high. Chronic critical illness (CCI), defined as persistent inflammation and organ injury requiring prolonged intensive care, is a harbinger of poor long-term outcomes in sepsis survivors. Current dogma states that sepsis survivors are immunosuppressed, particularly in CCI. Investigation of this immune suppression in heterogeneous immune populations across distinct clinical trajectories and outcomes, along with limited sampling access, is accessible via single-cell RNA sequencing (scRNA-seq). Methods: scRNA-seq analysis was performed on healthy subjects (n=12), acutely septic patients at day 4 ± 1 (n=4), and those defined as rapid recovery (n=4) or CCI (n=5) at day 14-21. Differential gene expression and pathway analyses were performed on peripheral blood lymphocytes at both a population and annotated cell subset level. Cellular function was assessed via enzyme-linked immunosorbent spot (ELISpot), cytokine production analysis, and T-cell proliferation assays on an additional cohort of septic patients (19 healthy, 68 acutely septic, 27 rapid recovery and 20 classified as CCI 14-21 days after sepsis onset). Results: Sepsis survivors that developed CCI exhibited proportional shifts within lymphoid cell populations, with expanded frequency of CD8 + and NK cells. Differential expression and pathway analyses revealed continued activation in T cells and NK cells, with generalized suppression of B-cell function. Both T and NK cell subsets displayed transcriptomic profiles of exhaustion and immunosuppression in CCI, particularly in CD8 + T effector memory (TEM) cells and NK cells. Functional validation of T-cell behavior in an independent cohort demonstrated T cells maintained proliferative responses in vitro yet exhibited a marked loss of cytokine production. IFN-γ production at the acute phase (day 4 ± 1) was significantly reduced in subjects later classified as CCI. Discussion: Sepsis patients exhibit unique T-, B-, and NK-cell transcriptional patterns that are both time- and clinical trajectory-dependent. These transcriptomic and pathway differences in sepsis patients that develop CCI are associated with exhaustion in CD8 + TEM cells and NK cells. Understanding the specific immune system patterns of different cell subsets after sepsis at a molecular level will be key to the development of personalized immunotherapy and drug-targeting intervention. Clinical trial registration: https://clinicaltrials.gov/, identifier NCT02276417.

A genome-wide association study of survival in patients with sepsis

Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study

A Signature of Immune-Related Genes Correlating with Clinical Prognosis and Immune Microenvironment in Sepsis

Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: A prospective cohort study

Comprehensive analysis of senescence-associated genes in sepsis based on bulk and single-cell sequencing data

Unraveling the genetic and molecular landscape of sepsis and acute kidney injury: A comprehensive GWAS and machine learning approach

Characterization of a proteomic profile associated with organ dysfunction and mortality of sepsis and septic shock

An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis

Gene correlation network analysis to identify regulatory factors in sepsis

A gene network database for the identification of key genes for diagnosis, prognosis, and treatment in sepsis

Dynamic changes in human single-cell transcriptional signatures during fatal sepsis

Single-cell RNA sequencing and transcriptomic analysis reveal key genes and regulatory mechanisms in sepsis

Characterization of Early Peripheral Immune Responses in Patients with Sepsis and Septic Shock

Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia

Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults

Identification of Risk Factors for Sepsis-Associated Mortality by Gene Expression Profiling Analysis.

Unique lymphocyte transcriptomic profiles in septic patients with chronic critical illness

Genetic signature related to heme-hemoglobin metabolism pathway in sepsis secondary to pneumonia

Causal effects of gut microbiota on sepsis and sepsis-related death: insights from genome-wide Mendelian randomization, single-cell RNA, bulk RNA sequencing, and network pharmacology

Utilize proteomic analysis to identify potential therapeutic targets for combating sepsis and sepsis-related death

Screening of potential immune-related genes expressed during sepsis using gene sequencing technology